Biotech Investing During Bear Markets

TD Cowen Insights

TD Securities and TD Cowen द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री TD Securities and TD Cowen या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

5M ago 45:07

MP3•एपिसोड होम

Recorded on 11/10/23

TD Cowen analyst Yaron Werber speaks with Chris Garabedian, co-founder, chairman, and CEO of Xontogeny and Portfolio Manager of the Perceptive Advisors Ventures Fund. Chris shares his insights about 1) what makes or breaks a successful biotech from his time at Gilead, Celgene, and Sarepta, 2) how investing has changed now that interest rates are high and capital is expensive, and 3) his investment philosophy at Xontogeny and advice to other early-stage investors.

For Disclosures, click here bit.ly/3cPHkNW

https://go.td.com/PodcastDisclosure

211 एपिसोडस

#Business #TD Cowen #TD Securities #Insight #Research #News #Canada #Tds #Capital Markets #Banking #Thought Leadership #Equity Research #Dealer #Global Marketing #Geopolitics #Investment Banking